SHARE

Danone investing €70m in medical nutrition line

Danone is investing into a new medical nutrition line at its Steenvoorde site, which currently produces Danone’s specialised nutrition ranges for early life. From 2026, the site will produce up to 20m litres of oral nutrition supplements.

Certification Note

Certified B Corporation” is a trademark licensed by B Lab, a private non-profit organization, to companies like ours that have successfully completed the B Impact Assessment (“BIA”) and therefore meet the requirements set by B Lab for social and environmental performance, accountability, and transparency. It is specified that B Lab is not a conformity assessment body as defined by Regulation (EU) No 765/2008, nor is it a national, European, or international standardization body as per Regulation (EU) No 1025/2012. The criteria of the BIA are distinct and independent from the harmonized standards resulting from ISO norms or other standardization bodies, and they are not ratified by national or European public institutions.